Trending News
News
News
Head and Neck Cancer Organoid Biobank Created
Researchers have developed a biobank with organoids derived from patients with head and neck cancer (HNC) and have used this biobank to validate known HNC biomarkers.
News
Promising Treatment Target for Metastatic Breast Cancer Identified
New research reveals more about changes that happen to cancer cells when they metastasize and identifies a promising target for the treatment of metastatic breast cancer.
News
Targeting Uncontrolled Inflammation May Be Key To Treating Resistant Cancers
Researchers have identified how a specific gene mutation triggers an inflammatory cascade that may drive the development of treatment-resistant cancers.
News
Blood Test May Predict Responses to Chemoimmunotherapy
A newly identified biomarker can indicate which patients with non-small cell lung cancer will respond well to chemoimmunotherapy
News
How a Fatty Liver Can Promote Colorectal Cancer Spread
Researchers have detailed, at the cellular level, how fatty liver promotes the spread of colorectal cancer to the liver, which could change how the disease is managed in some patients.
News
Targeting Tumor Cell Interactions May Advance Colorectal Cancer Treatment
Researchers studying cell interactions in bowel cancer have identified innovative strategies to enhance how the body and drug treatments fight the disease.
News
Gene-Editing Approach Speeds Up Study of Cancer Mutations
Researchers at the Massachusetts Institute of Technology have developed a method of engineering specific cancer-associated mutations into mouse models, making studying their effects and testing new drugs faster and easier.
News
Novel AI Software Can Identify Interactions Among Genes in and Around Tumors
SpaceMarkers, a new machine learning software developed, can identify molecular interactions among distinct types of cells in and around a tumor.
News
Parameters for Predicting Cachexia Identified
A predictive model developed at São Paulo State University helps identify tumor biomarkers of cachexia.
News
Triple Drug Combination Slows Kidney Cancer Progression by 27%
Advanced kidney cancer progression was slowed by the addition of a targeted kinase inhibitor to a two-drug immunotherapy combination.
Advertisement